Subscribe To

Price Alert Latest News Economic Calendar News

BWV / Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom

CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th, 2022. Read More

Demo Live Account See Partner Details

Content Topics

Blue

Water

Vaccines

Present

Universal

Influenza

Conference

Oxford

United

Kingdom

Stock

BWV

Posted: Aug 24 2022, 14:00

Author Name: GlobeNewsWire

BWV News

By Zacks Investment Research
June 15, 2023

Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs

Blue Water (BWV) soars 62% after declaring its deal to purchase six FDA-approved products for $8.5 million. The agreement will help expand the company

By GlobeNewsWire
August 24, 2022

Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom

CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutic

By InvestorPlace
July 27, 2022

What Is Going on With Blue Water Vaccines (BWV) Stock Today?

Source: shutterstock.com/PhotobyTawat Blue Water Vaccines (NASDAQ: BWV ) stock is jumping more than 50% today despite having no news to offer. Based i

By Seeking Alpha
May 17, 2022

Blue Water Vaccines: Estimates And Expectations

Blue Water Vaccines has a long road ahead of it. The company has multiple drug candidates in its pipeline but has not yet started clinical trials.

By GlobeNewsWire
April 11, 2022

Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022

CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceuti

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.